KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Assets (2019 - 2025)

Castle Biosciences (CSTL) has disclosed Return on Assets for 7 consecutive years, with 0.04% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 8.0% to 0.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.04% through Dec 2025, down 8.0% year-over-year, with the annual reading at 0.04% for FY2025, 8.0% down from the prior year.
  • Return on Assets hit 0.04% in Q4 2025 for Castle Biosciences, down from 0.02% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.03% in Q4 2024 to a low of 0.21% in Q2 2023.
  • Historically, Return on Assets has averaged 0.08% across 5 years, with a median of 0.07% in 2024.
  • Biggest five-year swings in Return on Assets: dropped -10bps in 2021 and later increased 20bps in 2024.
  • Year by year, Return on Assets stood at 0.09% in 2021, then plummeted by -74bps to 0.15% in 2022, then rose by 13bps to 0.13% in 2023, then skyrocketed by 127bps to 0.03% in 2024, then tumbled by -221bps to 0.04% in 2025.
  • Business Quant data shows Return on Assets for CSTL at 0.04% in Q4 2025, 0.02% in Q3 2025, and 0.02% in Q2 2025.